AI | pharmaphorum

AI

Digital

Adopting AI platforms: A structured framework for thoughtful...

The adoption of AI platforms, particularly in sectors such as drug discovery and healthcare, is a complex and critical process.

Digital

Tech & Trials: What’s all this about AI, then?

Welcome to Tech & Trials – a guided tour to the world of AI and clinical trials.

Digital

Ask NAVLIN: The AI chatbot innovation driving a better globa...

Demonstrating EVERSANA’s commitment to innovation, a new artificial intelligence technology aims to improve NAVLIN for both existing and new customers.

Digital

How can digital technologies help pharma meet the changing n...

Digital technologies are transforming the pharmaceutical industry's ability to meet the evolving needs of healthcare professionals (HCPs) and patients.

Digital

Recursion, Exscientia, and AI drug discovery’s moment of tru...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger.

Digital

AI as an inventor: Defining ownership in the pharma sector

The global pharmaceutical industry is witnessing a surge in innovation, with the industry experiencing a 5% growth in the number of AI-related patent applications in Q1 2024 and

Adopting AI platforms: A structured framework for thoughtful...

Tech & Trials: What’s all this about AI, then?

Ask NAVLIN: The AI chatbot innovation driving a better globa...

How can digital technologies help pharma meet the changing n...

Recursion, Exscientia, and AI drug discovery’s moment of tru...

AI as an inventor: Defining ownership in the pharma sector

Pfizer takes 25-valent Prevnar follow-up into phase 3

Discover a new era of healthcare panel engagement: Grounded ...

AI

Editor's Picks